Table 2.

Treatment Outcomes

Outcome	All Patients (N = 172)		HBsAg/HBcAb Negative (n = 119)		HBsAg/HBcAb Positive (n = 53)		P
	No.	%	No.	%	No.	%
Response
CR/PR	122	71	92	77	30	57	0.022
PD/RD	29	17	16	14	13	24
Disease relapse	21	12	11	9	10	19
Predicted 3-year PFS (± SE)	67% (± 4%)		76% (± 4%)		52% (± 8%)		0.009
Death	16	9	7	6	9	17	0.21
Predicted 3-year OS (± SE)	88% (± 3%)		93% (± 3%)		77% (± 7%)		0.012

Abbreviations: CR/PR Complete response/partial response, PD/RD Progressive disease/refractory disease